Close
The page header's logo
Help
Login
Staff Login
Register
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
AstraZeneca vaccine to remain authorized in Canada
play button
CP121635062 | AstraZeneca vaccine to remain authorized in Canada 
N.S. pauses use of AstraZeneca vaccine
play button
CP123262421 | N.S. pauses use of AstraZeneca vaccine 
AstraZeneca vaccine authorized in Canada
play button
CP118971421 | AstraZeneca vaccine authorized in Canada 
Ontario to get more than 250,000 AstraZeneca doses
play button
CP123251321 | Ontario to get more than 250,000 AstraZeneca doses 
AstraZeneca COVID-19 vaccine now recommended for Canadian seniors
play button
CP120124021 | AstraZeneca COVID-19 vaccine now recommended for Canadian seniors 
Newly eligible people receive Oxford-AstraZeneca vaccine
play button
CP121946460 | Newly eligible people receive Oxford-AstraZeneca vaccine 
AstraZeneca blood clot risk remains low: Tam
play button
CP122017117 | AstraZeneca blood clot risk remains low: Tam 
Second-dose choice likely for AstraZeneca recipients: Tam
play button
CP123597771 | Second-dose choice likely for AstraZeneca recipients: Tam 
Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
play button
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine 
Newsroom Ready: AstraZeneca vaccine authorized in Canada
play button
CP118972171 | Newsroom Ready: AstraZeneca vaccine authorized in Canada 
Action button
Placeline/People
City Vaughan
Country Canada

AstraZeneca vaccine's benefits vastly outweigh risks: Sharma

Health Canada's chief medical adviser Dr. Supriya Sharma says federal regulators are closely monitoring scientific findings about whether the Oxford-AstraZeneca vaccine against COVID-19 can lead to dangerous blood clots in a tiny percentage of recipients. But she says there's clear evidence the vaccine is extremely good at preventing COVID-19 and that vastly outweighs any potential risks. 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Canadian Press
Unique identifier: CP120476771 
Legacy Identifier: n_COVID-Cda20210323T1400 
Type: Video 
Duration: 1m47s 
Dimensions: 1920px × 1080px     123.11 MB 
Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE. 
Create Date: 3/23/2021 2:00:00 PM 
Display aspect ratio: 16:9 
Tags
AstraZeneca
Canada
canada government
Coronavirus
COVID-19
doses
health
Ontario
Ottawa
safety
vaccine
vaccines